This comprehensive review addresses the complexities in diagnosing and managing adrenal insufficiency (AI), encompassing primary, secondary, and tertiary forms. It highlights that patients with AI experience increased mortality, morbidity, and reduced quality of life, partly due to glucocorticoid replacement therapies failing to mimic physiological cortisol rhythms. The article emphasizes the
